Neos Therapeutics, Inc.
Neos Therapeutics, Inc. (NEOS) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 119 transactions totaling $10.5M, demonstrating a bullish sentiment with $3.9M in net insider flow. The most recent transaction on Mar 19, 2021 involved a transaction of 126,245 shares valued at $0.
NEOS Insider Activity Summary
Who Is Buying NEOS Stock?
No significant insider buying has been recorded for NEOS in the recent period.
Who Is Selling NEOS Stock?
No significant insider selling has been recorded for NEOS in the recent period.
Is Neos Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NEOS is bullish with an Insider Alignment Score of 69/100 and a net flow of $3.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
NEOS Frequently Asked Questions
Understanding NEOS Insider Activity
Insider trading at Neos Therapeutics, Inc. (NEOS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading NEOS stock, having executed 119 transactions in the past 90 days. The most active insider is James E. Flynn (Executive), who has made 8 transactions totaling $11.0M.
Related Tools
Track Neos Therapeutics, Inc. Insider Activity
Get notified when executives and directors at NEOS file new Form 4 transactions